The Trump administration finalized a survey of hospitals to acquire the payment rates for drugs purchased under the 340B discount program, much to the dismay of hospitals.
The Centers for Medicare & Medicaid Services on Friday published a notice on the survey in the Federal Register, calling for comments on the survey until March 9. Hospitals have been opposed to the survey, saying the survey request will cost too much and is flawed. READ MORE